X
skip to main content
Logo
media conference

Press Releases

  • February 15, 2018

    Therapeutic target EZH2 discovered for aggressive, untreatable ovarian cancer affecting young women

    A Vancouver team led by TFRI-funded investigator Dr. David Huntsman has discovered an important therapeutic target for treating small cell carcinoma of the ovary, hypercalcemic type (SCCOHT). This is a rare, but extremely lethal, ovarian cancer in young women with no effective treatment.

  • February 15, 2018

    Made-in-Canada model for detecting lung cancer saves lives, is a world leader

    A pan-Canadian TFRI team of cancer researchers has developed a predictive model for detecting early-stage lung cancer in high-risk individuals with significantly greater accuracy than other leading models. This study suggests the team’s innovative approach could be considered for use in lung cancer screening programs both in Canada and around the world.

  • February 15, 2018

    Nuclear mTOR acts as a transcriptional regulator of metabolism in prostate cancer, groundbreaking study finds

    A recent study by TFRI’s cancer metabolism group suggests nuclear mTOR (a kinase) also works as a transcriptional regulator of metabolism in the proliferation of prostate cancer.

  • February 15, 2018

    Vanadium compounds enhance efficacy of oncolytic viruses when used in combination therapy

    A new class of compounds is generating excitement for its ability to enhance the efficacy of oncolytic viruses (OVs) and to stimulate the immune response against tumours when used in combination therapy.

  • February 15, 2018

    Ultrasound-stimulated microbubbles enhance radiation effect on prostate cancer cells

    What if there was a way to make cancer cells more susceptible to radiation therapy without damaging healthy cells? New findings from Toronto researchers have shown ultrasound- stimulated microbubbles is a novel type of treatment that may achieve just that.

  • February 15, 2018

    Study finds mitochondrial mutations drive prostate cancer aggression

    While nuclear mutations are widely acknowledged as a driver of cancer tumours, the role of maternally inherited mitochondrial genome mutations has not been extensively explored – but now a paper from a prolific TFRI-funded team has suggested an important interplay between the two mutations when it comes to prostate cancer tumours.

  • January 19, 2018

    2017 TFRI Ontario Node Day Photos

    The annual Terry Fox Research Institute’s Ontario Node Research Symposium took place Monday, Dec. 4, 2017 at the MaRS Discovery Centre in Toronto. Photos of the event are now posted, check out the gallery here.

  • December 12, 2017

    The Potential of Precision Medicine: TFRI's 2017 ASM Photos Now Online

    More than 200 cancer researchers attended TFRI's 8th Annual Scientific Meeting in Vancouver on Nov. 4. Photos of the event are now posted, check out the gallery here.

  • December 07, 2017

    Milestone Videos: TFRI Celebrates 10th Anniversary

    This was a big year for the Terry Fox Research Institute: 2017 marked our 10th anniversary. Here are two videos we created to celebrate this milestone, telling the story of TFRI's origins, and how we are achieving Terry Fox's dream of finding cures for cancer through research.

  • November 24, 2017

    Canadian pediatric researchers, funders join forces, commit $16.4M to give young people across the country a fighting chance against cancer

    For the first time in Canadian history, more than 30 pediatric cancer research and funding organizations have joined forces through Terry Fox PROFYLE, a pan-Canadian project to give children, adolescents and young adults who are out of conventional treatment options another chance to beat their cancer.

  • October 26, 2017

    B.C. Lung Screen Trial recruiting 2,000 people for cancer screening study

    The B.C. Lung Screen Trial at Vancouver General Hospital is currently recruiting 2,000 individuals from the Lower Mainland who are between 55 and 80 years of age, with at least a 30-pack-years smoking history to take part in a new research project.

  • October 18, 2017

    Terry Fox research team’s model for detecting lung cancer saves lives, is a world leader: study

    A pan-Canadian team of cancer researchers has developed a predictive model for detecting early-stage lung cancer in high-risk individuals with significantly greater accuracy than other leading models. This Terry Fox Research Institute study suggests the team’s innovative approach could be considered for use in lung cancer screening programs both in Canada and around the world.

  • September 06, 2017

    Canadian, international researchers find new candidate drivers, subtype diversity in study of whole-genome landscape for children’s brain cancer

    A new study has analyzed hundreds of sequenced medulloblastoma (MB) samples, identifying new targets that could give children with this disease less harmful therapeutic options.

  • September 06, 2017

    Vancouver team identifies new class of molecules with potential in treating metastatic prostate cancer

    A recent study by a prolific TFRI-funded team has demonstrated that disrupting ERG transcriptional activity is sufficient to suppress the major characteristics of ERG-transformed prostate cancers.

  • September 06, 2017

    Vaccine shows promise in models, eradicates intra-abdominal tumours in over 90 per cent of mice

    Ontario cancer researchers have found that an oncolytic virus may lead to a promising new therapy option for patients with peritoneal carcinomatosis, a disseminated intra-abdominal tumour.

Back to Top